Elcatonin

依降钙素

Report date: 2023/02/08 16:14:36
NME

Base Information

Drug NameElcatonin
Drug Alias NameElcatoninaElcatonineElcatoninumDiatinElcitonin +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcitonin receptor inhibitors
TargetsCalcitonin receptor
Therapy Area/IndicationsHemiplegiaOsteoporosis
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaOsteoporosis
Original Approved Country/TerritoryJapan
Original Approved Date1981/09/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAsahi Kasei Pharma America Corp
China Registration ClassN/A

Develop Information

Active CompaniesLivzon Group Libao Biochemical Pharmaceutical Co LtdAsahi Kasei Pharma Corp
Inactive CompaniesAsahi Kasei Pharma America Corp
Active IndicationsOsteoporosis
Inactive IndicationsHemiplegia

Other Information

ATC CodeH05BA04
Related LinksWikipediaKEGG